Despite advances in diagnosis and treatment, chronic obstructive pulmonary disease (COPD) now affects up to 30 million Americans, with an estimated 12 million individuals remaining undiagnosed. In this eNewsletter, an expert in respiratory care describes how to apply evidence-based screening tools to detect undiagnosed COPD, and she reviews the 2018 treatment guidelines from the Global Initiative for Chronic Obstructive Lung Disease (GOLD).
eNewsletter with interactive benchmarking
To educate nurse practitioners (NPs) and physician assistants (PAs) on using effective screening tools to detect undiagnosed COPD, and to subsequently optimize treatment according to current practice guidelines.
After completing this activity, participants should be better able to:
- Identify patients with signs and symptoms of COPD in order to facilitate early diagnosis
- Implement assessment and risk stratification of patients with COPD through the use of validated clinical tools, including spirometry
- Formulate treatment strategies for COPD based on guideline recommendations, including patient-centered strategies to improve adherence to therapy, control symptoms, and minimize exacerbations
NPs and PAs
In support of improving patient care, Continuing Education Alliance is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Nursing contact hours: 1.00, which includes 1.00 hours of pharmacology credit.
This program has been reviewed and is approved for a maximum of 1.0 AAPA Category 1 CME credits by the AAPA Review Panel. Approval is valid for one year from the issue date of December 28, 2017. Participants may submit the post-test at any time during that period.
This program was planned in accordance with AAPA CME Standards for Enduring Material Programs and for Commercial Support of Enduring Material Programs.
This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.
The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Continuing Education Alliance, Practicing Clinicians Exchange, the AAPA, or Boehringer Ingelheim Pharmaceuticals, Inc.
All faculty and planners participating in continuing education activities sponsored by Continuing Education Alliance are expected to disclose to the audience any significant support or substantial relationships with providers of commercial products and/or devices discussed in this activity and/or with any commercial supporters of the activity. In addition, all faculty are expected to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and planning committee have been advised that this activity must be free from commercial bias, and based upon all the available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.
Ms Garvey: speakers bureau: Boehringer Ingelheim.
The Planning Committee for this activity included Ruth Cohen, Warren Beckman, and Annie Cheang of Continuing Education Alliance; and Mark Christiansen, PhD, PA-C, of the University of the Pacific. The members of the Planning Committee have no significant relationships to disclose.
Participants wishing to earn CE/CME credit must:
- Read the eNewsletter in its entirety
- Relate the content material to the learning objectives
- Complete the post-test and evaluation form online
Successful completion of the post-test is required to earn CE/CME credit. Successful completion is defined as a cumulative score of at least 70%.
The estimated time to complete this activity is 1.00 hours.
Release date: December 28, 2017
Expiration date: December 28, 2018
© 2018 Practicing Clinicians Exchange. All Rights Reserved. BIPCE93417